Skip to main content
MADRIGAL PHARMACEUTICALS, INC. logo

MADRIGAL PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · MDGL ISIN · US5588681057 LEI · 549300CHIMT2EUSNJB60 US Manufacturing
Filings indexed 1,022 across all filing types
Latest filing 2017-03-06 Director's Dealing
Country US United States of America
Listing US MDGL

About MADRIGAL PHARMACEUTICALS, INC.

https://www.madrigalpharma.com/

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious and progressive liver disease with high unmet medical need. The company's research led to the first U.S. Food and Drug Administration (FDA)-approved treatment for MASH. Madrigal's therapeutic goal is to halt or reverse liver scarring (fibrosis) and resolve the disease before patients experience severe complications, including cirrhosis, liver failure, and the need for transplantation.

Recent filings

Filing Released Lang Actions
FORM 4 -
Director's Dealing
2017-03-06 English
FORM 4 -
Director's Dealing
2016-11-21 English
FORM 3 -
Director's Dealing
2016-11-21 English
10-Q/A
Interim / Quarterly Report Q3 2016
2016-11-16 English
10-Q
Interim / Quarterly Report Q3 2016
2016-11-14 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 14, 2016, by Madrigal Pharmaceuticals, Inc. It specifically mentions Item 2.02 "Results of Operations and Financial Condition" and states that the company issued a press release announcing its financial results for the third fiscal quarter ended September 30, 2016. The document includes the press release as Exhibit 99.1. The text indicates this is a current report announcing quarterly financial results, which aligns with an Earnings Release (ER). The document length is 3481 characters, which is relatively short but contains the actual press release announcing quarterly results, not just a notice of report availability. Therefore, it is classified as an Earnings Release (ER).
2016-11-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.